NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Clinical Guideline Centre (UK). Osteoporosis: Fragility Fracture Risk: Osteoporosis: Assessing the Risk of Fragility Fracture. London: Royal College of Physicians (UK); 2012 Aug. (NICE Clinical Guidelines, No. 146.)

Cover of Osteoporosis: Fragility Fracture Risk

Osteoporosis: Fragility Fracture Risk: Osteoporosis: Assessing the Risk of Fragility Fracture.

Show details

Appendix FReference list

1.
Altman DG. Prognostic models: a methodological framework and review of models for breast cancer. Cancer Investigation. 2009;27(3):235–243. [PubMed: 19291527]
2.
Altman DG, Royston P. What do we mean by validating a prognostic model? Statistics in Medicine. 2000;19(4):453–473. [PubMed: 10694730]
3.
Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605. [PubMed: 19477892]
4.
Aspray TJ, Stevenson P, Abdy SE, Rawlings DJ, Holland T, Francis RM. Low bone mineral density measurements in care home residents--a treatable cause of fractures. Age and Ageing. 2006;35(1):37–41. [PubMed: 16364932]
5.
Ben Sedrine W, Broers P, Devogelaer JPD, Kaufman JM, Goemaere S, Reginster J. Interest of a prescreening questionnaire to reduce the cost of bone densitometry. Osteoporosis International. 2002;13(5):434–442. [PubMed: 12086356]
6.
Brennan J, Johansen A, Butler J, Stone M, Richmond P, Jones S, et al. Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff. Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2003;14(6):515–519. [PubMed: 12730755]
7.
Burge RT, Worley D, Johansen A, Bhattacharyya S, Bose U. The cost of osteoporotic fractures in the UK: projections for 2000–2020. Journal of Medical Economics. 2001;4(1–4):51–62.
8.
Burton A, Altman DG. Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. British Journal of Cancer. 2004;91(1):4–8. [PMC free article: PMC2364743] [PubMed: 15188004]
9.
Collins G. Opening up multivariable prediction models: consensus based guidelines for transparent reporting. 2011. [Last accessed: 13 January 2011]. Available from: http://blogs​.bmj.com​/bmj/2011/08/03/gary-collins-opening-up-multivariable-prediction-models/
10.
Collins GS, Mallett S, Omar O, Yu LM. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Medicine. 2011;9:103. [PMC free article: PMC3180398] [PubMed: 21902820]
11.
Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928–935. [PubMed: 17309939]
12.
Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clinical Chemistry. 2008;54(1):17–23. [PubMed: 18024533]
13.
Cook NR, Paynter NP. Performance of reclassification statistics in comparing risk prediction models. Biometrical Journal. 2011;53(2):237–258. [PMC free article: PMC3395053] [PubMed: 21294152]
14.
Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Annals of Internal Medicine. 2009;150(11):795–802. [PMC free article: PMC2782591] [PubMed: 19487714]
15.
Curtis L. Unit costs of social health care. Personal Social Services Reseach Unit, University of Kent; 2010. Available from: http://www​.pssru.ac.uk​/pdf/uc/uc2010/uc2010.pdf.
16.
Department of Health. NHS reference costs 2009–2010. 2011. [Last accessed: 1 August 2011].
17.
Gaughran F, Walwyn R, Lambkin-Williams R, Whelan P, Chatterton K, Oxford J, et al. Flu: effect of vaccine in elderly care home residents: a randomized trial. J Am Geriatr Soc. 2007;55(12):1912–1920. [PubMed: 18081669]
18.
Godden S, Pollock AM. The use of acute hospital services by elderly residents of nursing and residential care homes. Health and Social Care in the Community. 2001;9(6):367–374. [PubMed: 11846815]
19.
Gopal RG, Jeanes A, Russell H, Wilson D, Atere-Roberts E, O’Sullivan D, et al. Effectiveness of short-term, enhanced, infection control support in improving compliance with infection control guidelines and practice in nursing homes: a cluster randomized trial. Epidemiol Infect. 2009;137(10):1465–1471. [PubMed: 19257913]
20.
Harrison EJ, Adams JE. Application of a triage approach to peripheral bone densitometry reduces the requirement for central DXA but is not cost effective. Calcified Tissue International. 2006;79(4):199–206. [PubMed: 16969598]
21.
Hayden JA, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Annals of Internal Medicine. 2006;144(6):427–437. [PubMed: 16549855]
22.
Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ. 2009;339:1291–1295. [PMC free article: PMC2779855] [PubMed: 19926696]
23.
Ito K, Hollenberg JP, Charlson ME. Using the osteoporosis self-assessment tool for referring older men for bone densitometry: a decision analysis. Journal of the American Geriatrics Society. 2009;57(2):218–224. [PubMed: 19207137]
24.
Jacob M, Lewsey JD, Sharpin C, Gimson A, Rela M, van der Meulen JH. Systematic review and validation of prognostic models in liver transplantation. Liver Transplantation. 2005;11(7):814–825. [PubMed: 15973726]
25.
Johansson H, Kanis JA, Oden A, Compston J, McCloskey E. A comparison of case-finding strategies in the UK for the management of hip fractures. Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2012;23(3):907–915. [PubMed: 22234810]
26.
Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Annals of Internal Medicine. 1999;130(6):515–524. [PubMed: 10075620]
27.
Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley DA, et al. Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporosis International. 2011;22(6):1873–1883. [PubMed: 20967422]
28.
Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis J. Does osteoporosis therapy invalidate FRAX for fracture prediction? Journal of Bone and Mineral Research. 2012. [EPUB]:n/a. [PubMed: 22392538]
29.
Little RA. Regression with missing x’s: a review. Journal of the American Statistical Association. 1992;87(420):1227–1237.
30.
MacLean FR, Thomson SA, Gallacher SJ. Using WHO-FRAX to describe fracture risk: experience in primary care. Scottish Medical Journal. 2012;57(1):8–13. [PubMed: 22179858]
31.
Mallett S, Royston P, Dutton S, Waters R, Altman DG. Reporting methods in studies developing prognostic models in cancer: a review. BMC Medicine. 2010;8:20. [PMC free article: PMC2856521] [PubMed: 20353578]
32.
Mallett S, Royston P, Waters R, Dutton S, Altman DG. Reporting performance of prognostic models in cancer: a review. BMC Medicine. 2010;8:21. [PMC free article: PMC2857810] [PubMed: 20353579]
33.
Marshall A, Altman DG, Royston P, Holder RL. Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study. BMC Medical Research Methodology. 2010;10:7. [PMC free article: PMC2824146] [PubMed: 20085642]
34.
McCann M, O’Reilly D, Cardwell C. A Census-based longitudinal study of variations in survival amongst residents of nursing and residential homes in Northern Ireland. Age and Ageing. 2009;38(6):711–717. [PubMed: 19752201]
35.
Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Research and Treatment. 2011 [PubMed: 22037780]
36.
Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009;338:b606. [PubMed: 19502216]
37.
Mueller D, Econ H, Gandjour A. Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women. Value in Health. 2009;12(8):1106–1117. [PubMed: 19706151]
38.
Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine. 2008;27(2):157–172. [PubMed: 17569110]
39.
Pencina MJ, D’Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Statistics in Medicine. 2012;31(2):101–113. [PMC free article: PMC3341978] [PubMed: 22147389]
40.
Pencina MJ, D’Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Statistics in Medicine. 2011;30(1):11–21. [PMC free article: PMC3341973] [PubMed: 21204120]
41.
Pencina MJ, D’Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clinical Chemistry and Laboratory Medicine. 2010;48(12):1703–1711. [PMC free article: PMC3155999] [PubMed: 20716010]
42.
Perel P, Edwards P, Wentz R, Roberts I. Systematic review of prognostic models in traumatic brain injury. BMC Medical Informatics and Decision Making. 2006;6:38. [PMC free article: PMC1657003] [PubMed: 17105661]
43.
Projecting Older People Population Information. 2011. [Last accessed: 31 January 2012].
44.
Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Statistics in Medicine. 2004;23(5):723–748. [PubMed: 14981672]
45.
Singer BR, McLauchlan GJ, Robinson CM, Christie J. Epidemiology of fractures in 15,000 adults: the influence of age and gender. Journal of Bone and Joint Surgery British Volume. 1998;80(2):243–248. [PubMed: 9546453]
46.
Steyerberg EW. Clinical prediction models: a practical approach to development, validation and updating. Springer; 2009.
47.
Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128–138. [PMC free article: PMC3575184] [PubMed: 20010215]
48.
van der Heijden GJ, Donders AR, Stijnen T, Moons KG. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol. 2006;59(10):1102–1109. [PubMed: 16980151]
49.
Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. Journal of Clinical Epidemiology. 2005;58(5):475–483. [PubMed: 15845334]
50.
Vickers AJ, Cronin AM. Everything you always wanted to know about evaluating prediction models (but were too afraid to ask) Urology. 2010;76(6):1298–1301. [PMC free article: PMC2997853] [PubMed: 21030068]
51.
Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Medical Decision Making. 2006;26(6):565–574. [PMC free article: PMC2577036] [PubMed: 17099194]
52.
Wallace E, Smith SM, Perera-Salazar R, Vaucher P, McCowan C, Collins G, et al. Framework for the impact analysis and implementation of Clinical Prediction Rules (CPRs) BMC Medical Informatics and Decision Making. 2011;11:62. [PMC free article: PMC3216240] [PubMed: 21999201]
53.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine. 2011;155(8):529–536. [PubMed: 22007046]
Copyright © 2012, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

Bookshelf ID: NBK115318
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.0M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to pubmed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...